Product
Car-T Cells
1 clinical trial
8 indications
Indication
Non-Hodgkin LymphomaIndication
Mantle Cell LymphomaIndication
Chronic Lymphocytic LeukemiaIndication
Follicular LymphomaIndication
Marginal Zone LymphomaIndication
Diffuse Large B-Cell LymphomaIndication
Primary central nervous system lymphomaClinical trial
Phase I/II Study of Tandem, Bispecific Anti-CD19 Anti-CD20 CAR-T Cells for Patients With Relapsed and/or Refractory B Cell MalignanciesStatus: Recruiting, Estimated PCD: 2025-01-01